Dr. Sameh G. Abuerreish, MD

Dr. Abuerreish practices at Banner Primary Care Sun City West in Sun City West, Arizona.

Dr. Abuerreish's NPI, 1447246202, was assigned on September 26, 2005. Dr. Abuerreish holds Kansas license 0434951.

Dr. Abuerreish's primary practice is Banner Primary Care Sun City West, at 14416 W Meeker Blvd, Sun City West, AZ 85375 in Maricopa County. The practice phone is (623) 583-5270.

Dr. Abuerreish's primary practice is Banner Primary Care Sun City West in Sun City West, Arizona. Dr. Abuerreish is also affiliated with Sterling Regional MedCenter. The medical group on file is Banner Hospital Based Physicians Colorado. Dmand AI also links Dr. Abuerreish to 4 more hospitals, 3 medical groups, 1 group practice or clinic and 1 ambulatory surgery center, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Abuerreish practices, 7 sites in all. Vendor and product names are available with a free account.

Hematology and oncology is Dr. Abuerreish's primary specialty in the NPI Registry, under taxonomy code 207RH0003X. Dmand AI has Dr. Abuerreish's licenses on file in 3 states: Kansas, Indiana and West Virginia.

CMS data shows 315 Medicare services from Dr. Abuerreish across 5 procedure codes in 2024, all of them office visits, for 169 Medicare patients. Medicare paid $31,990 for them. Every service was in an office.

CMS counts 169 Medicare patients who saw Dr. Abuerreish in 2024. The largest group is 75 to 84, with 75 patients. 72% of them have high blood pressure, and 51% have high cholesterol. 13% are also on Medicaid. Their average risk score is 1.65, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Abuerreish's median patient age at 72, with 58% women.

In 2024, Dr. Abuerreish wrote 534 Medicare Part D claims for 71 patients. 86% of them were for generic drugs. CMS names the drug for 254 of them, across 14 drugs with 11 or more claims each, at $355,297 in total drug cost. In 2023, CMS named 405 claims across 21 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 88 out of 100 for Dr. Abuerreish for performance year 2024, reported as part of a group. Dr. Abuerreish accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Abuerreish as offering telehealth.

CMS Open Payments shows 6 general payments to Dr. Abuerreish from 6 drug and device companies from 2016 to 2017. Food and beverage make up the largest share, 89% of the total. Amgen Inc. paid the most, $49.